Viewing Study NCT03661632


Ignite Creation Date: 2025-12-24 @ 9:42 PM
Ignite Modification Date: 2025-12-30 @ 8:49 PM
Study NCT ID: NCT03661632
Status: COMPLETED
Last Update Posted: 2021-11-08
First Post: 2018-08-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: An Investigational Immunotherapy Study of BMS-986310 Administered Alone and in Combination With Nivolumab in Patients With Advanced Solid Tumors
Sponsor: Bristol-Myers Squibb
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module